| Puppyroach said: Considering the number of people in the US with Chronic HCV is estimated to be 3,5 million, that investment would pay for itself within a few years with those prices, so it´s obvious that the prices are set to maximize profit. That is the correct way for a company to go about it, but it is rather an argument for the government to do the research instead. |
Government funded research wouldn't work to the same degree unless they offered similarly competitive salaries for pharmacologists/biochemists like the private big pharma companies at which point the undertaking of drug development is just as capitally intensive ...
Pharmaceutical research scientists have unbelievable bargaining power because of their indispensable skills in producing drug candidates ...
The higher value future doesn't consist of Apple, Amazon, Facebook, Google, Microsoft or even Tencent but rather it will be Pfizer, Roche, Sanofi, Johnson & Johnson, Merck, Novartis, AbbVie, and Gilead ...
In the not too distant future the former will live in the past where their time ticking bombs will be entering the post silicon world. (many of the computer scientists and engineers will become obsolete and at that point we'll be seeing unions formed for those professions) As people age and nations keep getting more developed there will be more demand for spending specialty drugs that will lead to the latter's meteoric rise ... (the next hot thing will be biologics rather than as seen with consumer electronics for past decades)
Making humanity a better race means that they need to also produce life enhancing drugs too (intelligence, strength, and other desirable abilities) rather than just life saving drugs ... (I can foretell that there is a massive market to eugenics in which big pharma will be a key instrument)
